You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 112 No. 6, June 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Immunologic Responses in Patients With Lepromatous Leprosy

Thomas H. Rea, MD; Francisco P. Quismorio, MD; Brian Harding, PhD; Kenneth M. Nies, MD; Philip J. Di Saia, MD; Norman E. Levan, MD; George J. Friou, MD

Arch Dermatol. 1976;112(6):791-800.


Abstract

• Immunologic responses were measured in 46 patients with lepromatous leprosy. These patients were not distinguishable from controls on the basis of responses to soluble intradermal antigens, sensitization to contactants, peripheral blood T- and B-cell percentages, in vitro lymphocyte responses to a mitogen, or the prevalence of autoantibodies. Generalized immunologic abnormalities in patients with lepromatous leprosy are neither predisposing causes nor necessary accompaniments of lepromatous leprosy, but are probably remote sequellae of the illness. By implication, the generalized immunologic abnormalities reported in other diseases are likely to be remote sequellae of the particular illness.

(Arch Dermatol 112:791-800, 1976)



Author Affiliations

From the sections of dermatology (Drs Rea and Levan) and clinical immunology and rheumatic diseases (Drs Quismorio, Harding, and Friou), Department of Internal Medicine, and the Section of Gynecologic Oncology (Dr Di Saia), Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles; and the departments of dermatology, internal medicine, and obstetrics and gynecology, Los Angeles County-University of Southern California Medical Center. Dr Harding is now at the Radcliffe Infirmary, Oxford, England. Dr Nies is now at Harbor General Hospital, Torrance, Calif.


Footnotes

Accepted for publication Sept 10, 1975.

Reprint requests to Section of Dermatology, Los Angeles County-University of Southern California Medical Center, 2025 Zonal Ave, Los Angeles, CA 90033 (Dr Rea).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Quantitative Enhancement of Dinitrochlorobenzene Responsivity in Women Receiving Oral Contraceptives
Rea
Arch Dermatol 1979;115:361-362.
ABSTRACT  

Lucio's Phenomenon and Diffuse Nonnodular Lepromatous Leprosy
Rea and Levan
Arch Dermatol 1978;114:1023-1028.
ABSTRACT  

Current Concepts in the Immunology of Leprosy
Rea and Levan
Arch Dermatol 1977;113:345-352.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.